✦ LIBER ✦

Successful pegylated interferon alpha2a monotherapy for hepatitis C virus infection in a transplanted patient who relapsed after the preceding course

✍ Scribed by T. Ichikawa; N. Taura; H. Miyaaki; M. Matsuzaki; S. Eguchi; M. Takatsuki; T. Kanematsu; K. Nakao

Book ID: 110904496
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 87 KB
Volume: 13
Category: Article
ISSN: 1398-2273
DOI: 10.1111/j.1399-3062.2011.00609.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Response to Pegylated Interferon Alp

The Response to Pegylated Interferon Alpha 2a in Haemodialysis Patients with Hepatitis C Virus Infection

✍ S. C. Akhan; B. Kalender; M. Ruzgar 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

Late hepatitis B virus relapse in patien

Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin

✍ Potthoff, A.; Berg, T.; Wedemeyer, H. 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 511 KB

Relapse of hepatitis C virus after 14 mo

Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient

✍ Colson, Philippe; Bregigeon, Sylvie; Tourres, Christian; Solas, Caroline; Poizot 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 540 KB

Interferon alpha-2b and ribavirin in com

Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial

✍ Giuseppe Barbaro; Gabriella Di Lorenzo; Giancarlo Belloni; Luisella Ferrari; Ald 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Safety and efficacy of an induction dose

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study

✍ C. Tural; R. Solà; R. Rubio; M. Santín; R. Planas; C. Quereda; J. Berenguer; M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB